New sedative could help preterm babies breathe on their own faster
NCT ID NCT06878703
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two sedatives, dexmedetomidine and midazolam, in very premature babies who need a breathing tube. The goal is to see if dexmedetomidine helps them come off the ventilator sooner, which could reduce lung injury. About 380 babies born before 32 weeks will take part across multiple hospitals.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dexmedetomidine
- What this could lead to
- If it works, this could lead to a safer sedation option for preterm babies, helping them get off ventilators sooner and reducing lung damage.
- What could go wrong
- This is a phase 3 trial, but results may not apply to all preterm infants. Dexmedetomidine may not shorten breathing tube time as hoped, and side effects like low heart rate are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRETERM NEONATE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Armand Trousseau, APHP Service : Department of Neonatology
RECRUITINGParis, 75012, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tiny skin patch track preterm Babies' temperature continuously?
- New imaging tool could help preterm babies breathe easier
- Tiny sensors may predict when preemies can breathe on their own
- Radiation-free lung scans could protect tiniest babies
- New study aims to improve breathing tube decisions for tiniest preemies
- Gentle touch: acupressure may help preemies breathe better